Astrazeneca Pharma India standalone net profit declines 26.62% in the September 2024 quarter
Sales rise 31.16% to Rs 408.00 crore
Net profit of Astrazeneca Pharma India declined 26.62% to Rs 38.43 crore in the quarter ended September 2024 as against Rs 52.37 crore during the previous quarter ended September 2023. Sales rose 31.16% to Rs 408.00 crore in the quarter ended September 2024 as against Rs 311.07 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales408.00311.07 31 OPM %12.8816.96 -PBDT60.3560.63 0 PBT51.0356.95 -10 NP38.4352.37 -27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2024 | 7:49 AM IST